PRSS1<sup>A16V</sup> germline mutation is common in a cohort of intraductal papillary mucinous neoplasms of the pancreas
Listen to this summary
The authors aimed to investigate the genetic alterations associated with intraductal papillary mucinous neoplasms (IPMNs) of the pancreas, specifically exploring the role of the PRSS1<sup>A16V</sup> germline mutation in these lesions. Their findings revealed that this mutation is present in a subset of IPMNs and is linked to clinical symptoms and imaging features indicative of early chronic pancreatitis, suggesting that inflammation may play a role in the biology and heterogeneity of these neoplasms.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Surgery
View all →Aug 8, 2026 · Surgery
Unveiling the lessons from a virtual tobacco cessation program targeting surgical patients
Aug 8, 2026 · Surgery
Return to intended oncologic therapy after treatment for cholecystitis in cancer patients
Aug 7, 2026 · Surgery
Diagnostic performance of computed tomography in differentiating appendiceal diverticulitis from acute appendicitis
Aug 7, 2026 · Surgery
First insights into the microbiome of leaks following foregut surgery
Aug 6, 2026 · Surgery
Parenchyma-sparing pancreatectomy for solid pseudopapillary neoplasm of the pancreas: A propensity-matched analysis
Aug 6, 2026 · Surgery
Younger age is associated with higher recurrence after primary ventral hernia repair: A nationwide register- and survey-based study
More in Surgery
View all →Aug 10, 2026 · Critical care medicine
Heterogeneous Treatment Effects of Renal Replacement Therapy in Critically Ill Patients: A Multicenter Observational Study Using a Japanese ICU Registry
Aug 10, 2026 · Critical care medicine
A 1-Hour Resuscitation Bundle for Prehospital Management of Septic Shock
Aug 10, 2026 · Critical care medicine
Updating the Epidemiology of Pediatric Critical Care in the United States: 2001-2022
Aug 8, 2026 · Annals of surgical oncology
Early-Onset Appendiceal Adenocarcinoma (Age < 50 Years): Temporal Trends in Case Proportions, Histologic Patterns, and Survival Outcomes From SEER, 2000-2023
Aug 8, 2026 · Annals of surgical oncology
A Pathology-Based Model for Postoperative Recurrence or Metastasis Prediction and Adjuvant Immunotherapy Implications of Clear-Cell Renal Cell Carcinoma: A Multicenter, Retrospective Study
Aug 8, 2026 · Annals of surgical oncology
Comparison of 2015 and 2025 ATA Risk Stratification Systems for Predicting Recurrence in Papillary Thyroid Carcinoma
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


